Search results for Girentuximab
Girentuximab, Abbexa, abx831190
Girentuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CA9, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).
Host
Human, Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Girentuximab Biosimilar - Research Grade, ichor.bio, ICH5013
Detects human Carbonic Anhydrase IX. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Girentuximabï؟½Biosimilar - Research Grade.
Host
CHO cells
Reactivity
Human
Applications
Conjugation
Girentuximab Vedotin Biosimilar - Research Grade, ichor.bio, ICH5013V
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.